×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

News Highlights: EC bans Mamata from campaigning from 8 pm of April 12 till 8 pm of April 13

Track Deccan Herald's latest updates of news in India and across the world.
Last Updated 12 May 2021, 10:39 IST
14:1212 Apr 2021

Mamata Banerjee has been banned by ECfrom campaigning from 8 pm of April 12 till 8 pm of April 13.

13:0012 Apr 2021

   Retail inflation rose to 5.52 per cent in March, mainly on account of higher food prices, government data showed on Monday.

10:2512 Apr 2021

The Centre has approved Russia's Covid-19 vaccine Sputnik V for emergency use.

09:3112 Apr 2021

Given the current Covid-19 situation in Maharashtra, we’ve postponed state board exams for class 10th & 12th. Class 12th exams will be held by end of May, while 10th standard exams will be in June: Maharashtra Education Minister

Fresh dates will be announced accordingly, Education Minsiter varsha Gaikwad said said.

We'll also be writing to the CBSE, ICSE, IB, Cambridge boards, requesting them to reconsider their exam date, she said.

07:2912 Apr 2021

D-Street waves red flags

Markets declined sharplu and the rupee dropped on Monday as Covid-19 cases continued to rise relentlessly as maharashtra mulls a lockdown, threatening to derail a recovery in Asia's third-largest economy.

The NSE Nifty 50 index was down 3.7% at 14,286.85 while the S&P BSE Sensex declined 3.55% to 47,846.97. The two indexes have now retreated 7%-8% each from their mid-February record highs.

The rupee weakened to a more than eight-month low of 75.1375 against the dollar.

India reported another record daily surge in coronavirus cases and overtook Brazil to be the second worst-hit country by Covid.

Stocks across most industries declined, with financial shares being hit the hardest. HDFC Bank, Reliance Industries and ICICI Bank were the top three drags on the Nifty 50, each falling 3%-5%.

The state-run banks index was down 9% and on track for its worst day in more than a year.

Cipla and Dr Reddy's, both sellers of COVID-19 medication, gained 3%-4% and were among the few gainers.

(Reuters)

(Published 12 April 2021, 01:54 IST)

Follow us on